Role of 3D Tomography in Breast Cancer
Status: | Completed |
---|---|
Conditions: | Breast Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 40 - Any |
Updated: | 7/16/2013 |
Start Date: | March 2010 |
End Date: | December 2012 |
Contact: | Avice O'Connell, MD |
Email: | avice_oconnell@urmc.rochester.edu |
Phone: | 585-487-3319 |
The primary aim of this pilot study is to define the role of dedicated cone beam breast
computed tomography in breast cancer imaging. This research is a prelude of a more
comprehensive clinical trial that may follow.
Inclusion Criteria:
- All women, age 40 or older, who are scheduled for biopsy after classification as
BI-RADS 4/5 and have had a screening or diagnostic full-field digital mammography
(FFDM) exam are eligible to participate, except for exclusions noted below.
- Able to provide informed consent.
Exclusion Criteria:
- Males
- Women less than 40 years old
- Pregnant women
- Lactating women
- Woman who have had bilateral mastectomies
- Women with physical limitations that may prohibit resting prone on the exam table,
such as, but not limited to: frozen shoulder, recent heart surgery, pace maker
- Women who are unable to tolerate study constraints, frail or unable to cooperate
- Women with large breasts that cannot be accommodated within the field of view of the
CT system
- Women who have received radiation treatments to the thorax for malignant and
nonmalignant conditions, such as (but not limited to)
- Treatment for enlarged thymus gland as an infant
- Irradiation for benign breast conditions, including breast inflammation after
giving birth
- Treatment for Hodgkin's disease
- Women who have participated in a prior breast clinical trial that gave additional
radiation dose, such as an additional mammogram.
- Women who have received large numbers of diagnostic x-ray examinations for monitoring
of disease such as (but not limited to)
- Tuberculosis
- Severe scoliosis
We found this trial at
1
site
Click here to add this to my saved trials